1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Yu, X.-Q. Prakash, O. Kanost, M.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking DK J.Pept.Res. JPERFA 2150 1397-002X 54 256 261 10.1034/j.1399-3011.1999.00136.x 10517164 Structure of a paralytic peptide from an insect, Manduca sexta. 1999 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2438.719 PARALYTIC PEPTIDE I 1 syn polymer PP I no no ENFAGGCATGYLRTADGRCKPTF ENFAGGCATGYLRTADGRCKPTF A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n pdbx_database_related pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-01-10 1 1 2008-04-27 1 2 2011-07-13 1 3 2017-12-20 RCSB Y RCSB 2000-12-21 REL REL This sequence occurs naturally in the tobacco hornworm, Manduca sexta sample The structures were determined using standard 2D homonuclear techniques structures with the least restraint violations,structures with the lowest energy 100 10 NOESY DQF-COSY 0 4.3 ambient 283 K simulated annealing 7 lowest energy 3 mM in 90% H2O, 10% D2O at pH 4.3 90% H2O/10% D2O Brunger, A.T. refinement X-PLOR 3.1 500 Varian UNITYPLUS GLU 0 n 1 GLU 0 A ASN 1 n 2 ASN 1 A PHE 2 n 3 PHE 2 A ALA 3 n 4 ALA 3 A GLY 4 n 5 GLY 4 A GLY 5 n 6 GLY 5 A CYS 6 n 7 CYS 6 A ALA 7 n 8 ALA 7 A THR 8 n 9 THR 8 A GLY 9 n 10 GLY 9 A TYR 10 n 11 TYR 10 A LEU 11 n 12 LEU 11 A ARG 12 n 13 ARG 12 A THR 13 n 14 THR 13 A ALA 14 n 15 ALA 14 A ASP 15 n 16 ASP 15 A GLY 16 n 17 GLY 16 A ARG 17 n 18 ARG 17 A CYS 18 n 19 CYS 18 A LYS 19 n 20 LYS 19 A PRO 20 n 21 PRO 20 A THR 21 n 22 THR 21 A PHE 22 n 23 PHE 22 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N THR 13 A N THR 14 A O ARG 17 A O ARG 18 1 A ARG 12 0.260 SIDE CHAIN 1 A ARG 17 0.272 SIDE CHAIN 2 A ARG 12 0.316 SIDE CHAIN 2 A ARG 17 0.317 SIDE CHAIN 3 A ARG 17 0.279 SIDE CHAIN 4 A ARG 12 0.128 SIDE CHAIN 4 A ARG 17 0.308 SIDE CHAIN 5 A ARG 12 0.310 SIDE CHAIN 5 A ARG 17 0.290 SIDE CHAIN 6 A ARG 12 0.229 SIDE CHAIN 6 A ARG 17 0.315 SIDE CHAIN 7 A ARG 12 0.297 SIDE CHAIN 7 A ARG 17 0.261 SIDE CHAIN 8 A ARG 12 0.161 SIDE CHAIN 8 A ARG 17 0.167 SIDE CHAIN 9 A ARG 12 0.318 SIDE CHAIN 9 A ARG 17 0.286 SIDE CHAIN 10 A ARG 12 0.256 SIDE CHAIN 10 A ARG 17 0.199 SIDE CHAIN 1 A ALA 7 -55.68 -156.98 1 A ARG 17 -160.00 -157.80 1 A THR 21 -85.04 30.06 2 A PHE 2 -129.49 -166.24 2 A ALA 3 44.48 70.29 2 A ALA 7 -55.70 -152.56 2 A ALA 14 -64.73 3.01 2 A ARG 17 -160.15 -157.48 3 A ALA 7 -54.72 -158.40 3 A ARG 12 -45.04 151.04 3 A ARG 17 -160.01 -147.41 3 A THR 21 -89.42 40.45 4 A ASN 1 -51.22 106.61 4 A ALA 3 32.78 61.17 4 A ALA 7 -57.40 -148.63 4 A TYR 10 -106.50 -168.92 4 A ARG 12 -33.19 108.76 4 A ALA 14 -63.50 1.27 4 A ARG 17 -144.60 -141.93 5 A ASN 1 -37.12 127.95 5 A PHE 2 -102.92 -158.03 5 A ALA 7 -55.16 -160.93 5 A THR 8 -46.24 101.43 5 A ARG 12 -38.50 140.52 5 A ALA 14 -67.40 1.46 5 A ARG 17 -158.01 -154.06 5 A THR 21 -85.77 44.66 6 A ALA 7 -57.67 -145.34 6 A ARG 12 -37.30 133.60 6 A ALA 14 -65.42 2.20 6 A ARG 17 -157.81 -142.91 6 A THR 21 -87.47 33.92 7 A ASN 1 47.61 -168.30 7 A ALA 3 60.55 60.61 7 A ALA 7 -52.87 -168.29 7 A LEU 11 -138.97 -158.59 7 A ALA 14 -66.34 1.85 7 A ARG 17 -155.15 -146.88 8 A ASN 1 74.29 45.34 8 A PHE 2 48.04 -171.78 8 A ALA 7 -56.75 -150.87 8 A ARG 12 -39.38 114.47 8 A ALA 14 -64.50 6.51 8 A ARG 17 -154.41 -142.54 8 A THR 21 -92.56 56.09 9 A ASN 1 56.87 111.39 9 A PHE 2 -116.29 -160.03 9 A ALA 7 -54.27 -161.13 9 A ARG 12 -25.97 110.85 9 A ALA 14 -65.46 2.16 9 A ARG 17 -151.53 -139.02 10 A ASN 1 60.72 127.48 10 A PHE 2 -103.83 -155.48 10 A ALA 7 -60.03 -141.66 10 A TYR 10 -104.24 -167.07 10 A ARG 12 -35.85 113.00 10 A ALA 14 -68.52 4.47 10 A ARG 17 -159.95 -146.79 PARALYTIC PEPTIDE I STRUCTURE OF A PARALYTIC PEPTIDE FROM AN INSECT, MANDUCA SEXTA 1 N N disulf 2.018 A CYS 6 A SG CYS 7 1_555 A CYS 18 A SG CYS 19 1_555 TOXIN paralytic peptide, plasmatocyte spreading peptide, ENF family, toxin PAP1_MANSE UNP 1 1 P30253 ENFAGGCATGYLRTADGRCKPTF 1 23 1HRL 0 22 P30253 A 1 1 23 2 anti-parallel A TYR 10 A TYR 11 A THR 13 A THR 14 A ARG 17 A ARG 18 A PRO 20 A PRO 21 1 P 1